American ginseng could inhibit colon cancer development

HPLC, UHPLC

American ginseng could inhibit colon cancer development

10 Nov, 2011

Published over 14 years ago. See the latest and most current information on HPLC, UHPLC.

A study has been conducted to determine if American ginseng could be used to inhibit the development of colon cancer in people who consume a western diet.

The research aimed to decipher if ginseng could inhibit western diet promoted colonic tumorigenesis and if compound K, a microbial metabolite of ginseng, could suppress colon cancer xenograft growth.

Mice were initiated with azoxymethane (AOM) and were fed a western diet, containing 20 per cent fat, or a western diet supplemented with 250-ppm ginseng.

After one week, the mice received 2.5 per cent dextran sulphate sodium (DSS) for five days and were sacrificed 12 weeks after AOM introduction.

Tumours were harvested a cell proliferation measured by Ki67 staining and apoptosis by TUNEL assay.

Anti-tumour effects of intraperitoneal compound K were examined using a tumour xenograft model and compound K absorption measured following oral ginseng gavage by UPLC-mass spectrometry.

Researchers found that ginseng significantly inhibited colonic inflammation, tumorigenesis and concomitantly reduced proliferation and increased apoptosis.

Posted by Neil Clark

Latest News

Explore Our Other Sites

Labmate Online
Physics-based machine learning sharpens images taken through through fog, tissue, cloudy liquids
Explore more Arrow
Envirotech Online
East Asia expands cooperative POPs monitoring with greater focus on PFAS analysis
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
Beyond standard cetane testing: Unlocking research for the next generation of sustainable fuels
Explore more Arrow